Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 78, 2018 - Issue 4
Submit an article Journal homepage
105
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients

Hongbo LiDepartment of Vascular Surgery, People’s Hospital of Shouguang, Weifang, Shandong, China; ;Department of Vascular Surgery, Shandong Provincial Hospital, Jinan, Shandong, China; Correspondence[email protected]
View further author information
,
Hua GuiDepartment of Surgery, People’s Hospital of Shouguang, Weifang, Shandong, China; View further author information
,
Guohong YuanDepartment of Surgery, People’s Hospital of Shouguang, Weifang, Shandong, China; View further author information
,
Xiaomei ZhengDepartment of Vascular Surgery, People’s Hospital of Shouguang, Weifang, Shandong, China; View further author information
,
Changkuan GaoDepartment of Clinical Laboratory, Qilu Hospital, Jinan, Shandong, ChinaView further author information
&
Hai YuanDepartment of Vascular Surgery, Shandong Provincial Hospital, Jinan, Shandong, China; View further author information
Pages 269-274 | Received 23 Nov 2017, Accepted 03 Mar 2018, Published online: 19 Mar 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Weishuai Lian, Hongpeng Nie, Yifeng Yuan, Kun Wang, Weiqian Chen & Liangfu Ding. (2021) Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans. Journal of Investigative Surgery 34:7, pages 765-770.
Read now

Articles from other publishers (2)

Deshuang Xiao & Jun Song. (2022) Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Rihards Saksis, Ivars Silamikelis, Pola Laksa, Kaspars Megnis, Raitis Peculis, Ilona Mandrika, Olesja Rogoza, Ramona Petrovska, Inga Balcere, Ilze Konrade, Liva Steina, Janis Stukens, Austra Breiksa, Jurijs Nazarovs, Jelizaveta Sokolovska, Valdis Pirags, Janis Klovins & Vita Rovite. (2021) Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.